Table 3.
Group | D 1 | D 3 | D 5 | D 7 | D 10 | |
DAO (U/mL) | A | 10.15 ± 1.10 | 12.86 ± 1.35 | 15.76 ± 1.33 | 18.55 ± 1.77 | 21.83 ± 1.21 |
B | 22.36 ± 2.82a | 34.74 ± 5.59a | 44.54 ± 2.77a | 51.61 ± 1.70a | 68.02 ± 2.46a | |
C | 18.69 ± 2.17c | 29.79 ± 2.49c | 36.15 ± 3.98c | 40.13 ± 1.21c | 59.87 ± 4.34c | |
D-LA (g/L) | A | 4.12 ± 0.53 | 6.13 ± 0.57 | 8.62 ± 1.67 | 10.78 ± 0.72 | 11.67 ± 1.56 |
B | 6.32 ± 0.46a | 8.65 ± 0.62a | 10.46 ± 0.98a | 12.74 ± 0.68a | 17.74 ± 1.75a | |
C | 3.08 ± 0.32c | 4.08 ± 0.30c | 5.031 ±0.18c | 7.25 ± 0.51c | 12.81 ± 0.47c |
All values are mean ± SD (n = 6). A: Non-rejection group; B: Rejection group; C: Bone marrow mesenchymal stem cells therapy group.
P < 0.05 vs group A;
P < 0.05 vs group B. DAO: Diamine oxidase; D-LA: D-lactic acid.